| Listed site | cdmo | cdmo |
|---|
| Summary | Leading global CDMO offering end-to-end development and manufacturing for pharma, biotech, and consumer health—spanning oral dose, biologics, cell and gene therapies, clinical supply, and specialty formulations with advanced technologies and worldwide GMP capacity. | End-to-end CDMO specializing in complex modalities including cell, gene, and RNA-based therapies with North American manufacturing facilities and development capabilities. |
|---|
| Services | - Cell Therapy Manufacturing
- Viral Vector Manufacturing
- AAV Manufacturing
- Oral Solid Dosage Manufacturing
- Inhalation & Nasal Dosage Manufacturing
- Formulation Development
- Process Development
- CMC Analytical Development
- Technology Transfer
- Sterile Fill-Finish & Aseptic Manufacturing
- Quality Control Testing
- Recombinant Protein Manufacturing
- Biologics Development & Manufacturing
- API Synthesis & Manufacturing
- Small Molecule Development & Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
- Secondary Packaging & Labeling
- Stability Testing & Storage
- CMC Regulatory Submission Support
- Cell-Line Development
- Upstream Processing
- Downstream Processing
- Vial Filling
- Prefilled Syringe (PFS) Filling
- Topical & Semi-Solid Manufacturing
- Serialization & Track-and-Trace
- Cold-Chain Storage & Logistics
- Cartridge Filling
- Lyophilization (Freeze Drying)
- Lentiviral Vector Manufacturing
| - Formulation Development
- CMC Analytical Development
- Technology Transfer
- Process Development
- Sterile Fill-Finish & Aseptic Manufacturing
- Vial Filling
- Prefilled Syringe (PFS) Filling
- Cartridge Filling
- Autologous Cell Therapy Manufacturing
- Allogeneic Cell Therapy Manufacturing
- Cell Therapy Manufacturing
- Recombinant Protein Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
- Biologics Development & Manufacturing
- Bioconjugation Services
- Upstream Processing
- Downstream Processing
- Secondary Packaging & Labeling
- Quality Control Testing
- mRNA Manufacturing
- Vaccine Manufacturing
|
|---|
| Modalities | - Small Molecule
- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Cell Therapy
- Gene Therapy
- AAV / Viral Vector Platform
| - Biologics (Monoclonal Antibodies)
- Biologics (Other)
- mRNA
- Cell Therapy
- Gene Therapy
- Vaccine
|
|---|
| Indications | Data not yet provided. | Data not yet provided. |
|---|
| Locations | - Headquarters, United States
- Asia Pacific, Asia Pacific
- Europe, Europe
- Latin America, Latin America
- North America, North America, United States
- China, China
- Japan, Japan
- North America, North America
- Global Network
| - Headquarters, Blue Ash, OH, USA
- Cincinnati, Cincinnati, OH, USA
- Philadelphia, Philadelphia, PA, USA
- Toronto, Toronto, ON, Canada
- Fremont, Fremont, California, United States
|
|---|
| Certifications | - GMP · Identifier: Nine GMP facilities
| - FDA · Identifier: cGMP
- FDA · Identifier: PAI
- FDA · Identifier: PFS & Vial Approval
- Health Canada · Identifier: Health Canada
- EMA · Identifier: Virtual Inspection
|
|---|
| Reviews | Review summary appears after site-level review signal gate opens. | Review summary appears after site-level review signal gate opens. |
|---|